Sangamo Biosciences reported $1.53M in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31343M 96M
Avrobio Inc AVRO:US $ 4K 0
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
GlaxoSmithKline GSK:LN 1347M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Novartis NOVN:VX SF 890M 11M
Omeros OMER:US $ 627K 1000
Regulus Therapeutics RGLS:US $ 0.15M 0M
Sangamo Biosciences SGMO:US $ 1.53M 0.07M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M
Ziopharm Oncology ZIOP:US $ 0.22M 0M